ReviewThe role of central dopamine and serotonin in human obesity: lessons learned from molecular neuroimaging studies
Introduction
Obesity now affects over 600 million adults worldwide [1]. It is associated with numerous cardiometabolic complications and forms a major threat to public health [2]. Obesity is caused by an imbalance between energy intake and expenditure. Its major driver is the persistent overconsumption of nutrients [3]. In this regard, it is highly relevant to determine why obese individuals continue to overconsume food under conditions where homeostatic needs have already been met.
Feeding behavior is mainly regulated by homeostatic and hedonic systems. The homeostatic system is primarily located in the hypothalamus and brainstem [4]. It receives and integrates input on energy availability from multiple peripheral organs and brain regions, and it adjusts food intake to balance energy availability and expenditure [5]. This system is closely connected to the hedonic system, which is involved in the motivational and rewarding aspects of food intake [6]. The striatum, one of the nuclei in the subcortical basal ganglia, has been identified as the center of the hedonic system [7]. This region can be subdivided in a ventral part, which includes the nucleus accumbens, and a dorsal part, which includes parts of the caudate nucleus and putamen [8]. For recent reviews of the numerous neural circuits that control food intake, we refer to Ferrario et al. [9] and Schwartz and Zeltser [10].
The neurotransmitters dopamine and serotonin fulfill important roles in hedonic and homeostatic signaling, respectively, but other neurotransmitters are also involved [11], [12]. Numerous studies, in rodents and humans [13], [14], [15], [16], have shown that experimental stimulation or inhibition of dopaminergic and serotonergic signaling is associated with changes in feeding behavior, motivation to eat, (food-related) reward learning, and energy expenditure. On the basis of these and other observations, it has been hypothesized that disturbed feeding behavior in obesity is caused by alterations in central dopamine and serotonin systems [16], [17]. Several neurotransmitter-related hypotheses have been generated to explain caloric overconsumption: i) the reward deficiency hypothesis states that food intake is increased to compensate for a diminished reward effect of food consumption due to decreased dopaminergic activity [18], and ii) the homeostatic hypothesis states that decreased hypothalamic serotonin signaling contributes to the overconsumption of food due to dysregulated homeostatic regulation [19].
Whereas animal studies have greatly enhanced our understanding of the neuronal pathophysiology of obesity (for reviews, see la Fleur and Serlie [20], Berthoud et al. [21], and Tulloch et al. [22]), it remains largely unknown how these paradigms translate to human obesity. In vivo molecular neuroimaging techniques provide attractive means to study the central dopamine and serotonin systems in human subjects, but seemingly conflicting results complicate the interpretation of the available data. Here, we aimed to comprehensively review the outcomes of neuroimaging studies on the regulation of food intake and body weight in humans. To this end, we will discuss current imaging methods, give an overview of the available evidence from human trials, and use this framework to explore how the data fit in with the major hypotheses of disturbed feeding behavior in human obesity.
Section snippets
Literature Search and Review Methods
We searched for relevant peer-reviewed English-language publications in the MEDLINE library (www.ncbi.nlm.nih.gov/pubmed) from inception through 24 August 2017. The literature search was focused on serotonin, dopamine, obesity, and related terms. We manually reviewed reference lists of selected articles for additional publications. Entries identified through the search were screened for relevance, and full-text articles were retrieved for in-depth review and methodological quality assessment.
Imaging of the Central Dopamine and Serotonin System
Methods to directly measure concentrations of dopamine and serotonin in the human brain are currently not available, but neuroimaging techniques have enabled us to assess markers of dopamine and serotonin signaling in vivo. With the use of radiopharmaceuticals (that is, radiotracers) and positron emission tomography (PET) or single photon emission computed tomography (SPECT), several dopamine and serotonin receptors and/or transporters can be visualized and quantified in the brain. Most studies
Results on Dopamine Receptors
Several studies have evaluated central D2R and D3R availability in relation to obesity (Table 3). Back in 2001, Wang et al. [18] reported for the first time that morbidly obese subjects have decreased striatal D2/3R BP. This has since been replicated in studies of morbidly obese subjects (BMI > 40 kg/m2) [35], [42], but other studies have not found such differences between lean and overweight/obese subjects [37], [38], [39]. In fact, two studies have found increased striatal D2/3R BP in obese
Changes in Phasic Dopamine Release
So far, we have focused on alterations in the tonic dopamine and serotonin release in obese subjects (that is, baseline imaging, without an active intervention). Physiologically, dopamine is released from the ventroanterior midbrain (substantia nigra and ventral tegmental area) to the striatum in a phasic manner in response to stimuli [71]. In rodents, dopamine release occurs after food cues, taste, consumption, and gut-brain signals [72], [73]. Some of these mechanisms have been translated to
Effects on the Dopamine System
Few longitudinal studies have assessed the effects of weight loss or gain on the cerebral dopamine system. Early after bariatric surgery (~ six weeks; ~ 15 kg lost), one study reported no change in striatal D2/3R BP [55], whereas one other study reported an increase in striatal D2/3R BP and another study reported a decrease in striatal D2/3R BP [37], [84]. These were small studies (five to 18 participants), and there were differences, among others, in operation techniques and neuroimaging methods,
Perspective
Central dopamine and serotonin are important mediators of feeding behavior in physiology and obesity, but our understanding of the role of these neurotransmitters in human obesity is limited. Current molecular neuroimaging technologies allow the spatial visualization and quantification of the receptors and transporters that are involved in central dopamine and serotonin systems, providing us with an attractive method to assess aspects of these systems in vivo. However, we stress that direct in
Concluding Remarks
The available evidence from human neuroimaging trials indicate that obesity may be associated with decreased dopaminergic and serotonergic signaling. These observations support the two major neurotransmitter theories of disturbed feeding behavior in obesity, where increased reward-seeking and decreased homeostatic feedback contribute to overconsumption of palatable food. Nevertheless, the limited number of neuroimaging studies, relatively small sample sizes, and difficult interpretation of the
Author Contributions
KAvG performed the search and study selection; KAvG and KWtH drafted the manuscript; JB, SElF, and MJS revised the manuscript.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Disclosure Statement
The authors declare that there is no conflict of interest associated with the manuscript.
References (104)
- et al.
Increased food energy supply is more than sufficient to explain the US epidemic of obesity
Am J Clin Nutr
(2009) Reward mechanisms in obesity: new insights and future directions
Neuron
(2011)- et al.
Putting a spin on the dorsal-ventral divide of the striatum
Trends Neurosci
(2004) - et al.
Aberrant mesolimbic dopamine-opiate interaction in obesity
Neuroimage
(2015) - et al.
Methylphenidate reduces energy intake and dietary fat intake in adults: a mechanism of reduced reinforcing value of food?
Am J Clin Nutr
(2007) - et al.
Brain serotonin system in the coordination of food intake and body weight
Pharmacol Biochem Behav
(2010) - et al.
Reward, dopamine and the control of food intake: implications for obesity
Trends Cogn Sci
(2011) - et al.
Brain dopamine and obesity
Lancet
(2001) - et al.
Association of central serotonin transporter availability and body mass index in healthy Europeans
Eur Neuropsychopharmacol
(2014) - et al.
The interaction between nutrition and the brain and its consequences for body weight gain and metabolism; studies in rodents and men
Best Pract Res Clin Endocrinol Metab
(2014)
Blaming the brain for obesity: integration of hedonic and homeostatic mechanisms
Gastroenterology
Neural responses to macronutrients: hedonic and homeostatic mechanisms
Gastroenterology
Molecular biology of dopamine receptors
Trends Pharmacol Sci
Striatal dopamine D2/3 receptor availability increases after long-term bariatric surgery-induced weight loss
Eur Neuropsychopharmacol
Effects of chronic citalopram treatment on 5-HT1A and 5-HT2A receptors in group- and isolation-housed mice
Eur J Pharmacol
Intracerebroventricular administration of 5,7-dihydroxytryptamine to mice increases both head-twitch response and the number of cortical 5-HT2 receptors
Neuropharmacology
No association between striatal dopamine transporter binding and body mass index: a multi-center European study in healthy volunteers
Neuroimage
Ventral striatum binding of a dopamine D(2/3) receptor agonist but not antagonist predicts normal body mass index
Biol Psychiatry
Associations between dopamine D2 receptor availability and BMI depend on age
Neuroimage
Serotonin transporter binding and acquired obesity — an imaging study of monozygotic twin pairs
Physiol Behav
Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers—a SPECT study
Neuroimage
Neuroreceptor imaging in depression
Neurobiol Dis
Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers
Neuroimage
A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables
Neuroimage
Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use
Neuroimage
Obesity is associated with high serotonin 4 receptor availability in the brain reward circuitry
Neuroimage
Cerebral serotonin transporter binding is inversely related to body mass index
Neuroimage
The acute and chronic effects of MDMA (“ecstasy”) on cortical 5-HT2A receptors in rat and human brain
Neuropsychopharmacology
Diet-induced changes in the lean brain: hypercaloric high-fat-high-sugar snacking decreases serotonin transporters in the human hypothalamic region
Mol Metab
Getting formal with dopamine and reward
Neuron
Striatal dopamine links gastrointestinal rerouting to altered sweet appetite
Cell Metab
Sensitivity to reward and body mass index (BMI): evidence for a non-linear relationship
Appetite
A functional neuroimaging review of obesity, appetitive hormones and ingestive behavior
Physiol Behav
Decreased dopamine type 2 receptor availability after bariatric surgery: preliminary findings
Brain Res
Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent
Nucl Med Biol
2-((2-((Dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand
Nucl Med Biol
Fact sheet: obesity and overweight
Metabolic complications of obesity
Endocrine
Serotonin and the regulation of mammalian energy balance
Front Neurosci
Central nervous system control of food intake and body weight
Nature
Neurobiology of food intake in health and disease
Nat Rev Neurosci
Homeostasis meets motivation in the battle to control food intake
J Neurosci
Functional organization of neuronal and humoral signals regulating feeding behavior
Annu Rev Nutr
Central nervous system control of food intake
Nature
Dopamine signaling in the dorsal striatum is essential for motivated behaviors: lessons from dopamine-deficient mice
Ann N Y Acad Sci
Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity
Curr Drug Targets
Consensus nomenclature for in vivo imaging of reversibly binding radioligands
J Cereb Blood Flow Metab
PET tracers for serotonin receptors and their applications
Cent Nerv Syst Agents Med Chem
Agonist high- and low-affinity states of dopamine D(2) receptors: methods of detection and clinical implications
Naunyn Schmiedebergs Arch Pharmacol
Measuring endogenous 5-HT release by emission tomography: promises and pitfalls
J Cereb Blood Flow Metab
Cited by (83)
Calorie restriction mitigates metabolic, behavioral and neurochemical effects of cafeteria diet in aged male rats
2023, Journal of Nutritional BiochemistryEffects of Lactobacillus acidophilus administration to anorexigenic neuropeptides and some biochemical parameters on rats fed with a high-fat diet
2023, Prostaglandins and Other Lipid MediatorsAnalytical evolution of measurement methods for light's non-visual effects
2023, Results in Engineering